Questcor Pharmaceuticals (QCOR) Slammed On Latest Negative Report
Get Alerts QCOR Hot Sheet
Join SI Premium – FREE
Questcor Pharmaceuticals (Nasdaq: QCOR) is good at making enemies. However, the company is also good at destroying them.
Today's Questcor finds itself the target of another negative blog post. This one from the king of short-selling blogs - Citron Research - which has an impressive track record being right with their negative views on individual stocks that they cover.
Citron has posted a 22-page report on Questcor with nasty comments like "snake oil salesmen," "single digit stock in 18 months."
Citron filed a Freedom of Information Act request and has obtained the FDA's approval history on ACTH, which they said "completely negate the "barrier to entry" claims of Questcor's CEO."
Citron's full report is here.
But Questcor is no stranger to negative short attacks. In fact, every short attack has been meet with two things - a higher stock price and pain for short sellers.
Shares of QCOR are down 7.5 percent.
Today's Questcor finds itself the target of another negative blog post. This one from the king of short-selling blogs - Citron Research - which has an impressive track record being right with their negative views on individual stocks that they cover.
Citron has posted a 22-page report on Questcor with nasty comments like "snake oil salesmen," "single digit stock in 18 months."
Citron filed a Freedom of Information Act request and has obtained the FDA's approval history on ACTH, which they said "completely negate the "barrier to entry" claims of Questcor's CEO."
Citron's full report is here.
But Questcor is no stranger to negative short attacks. In fact, every short attack has been meet with two things - a higher stock price and pain for short sellers.
Shares of QCOR are down 7.5 percent.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Buy the dip in US stocks in case of a 'rate shock' - Goldman
- Pullback in AI beneficiaries is 'a buying opportunity' - UBS
- World shares dip, yen slides amid landmark BOJ policy shift
Create E-mail Alert Related Categories
Insiders' Blog, Trader TalkRelated Entities
Citron ResearchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!